Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT07582692
NCT07582692CompletedNot Applicable

Effects of Sequential Prefrontal Alpha-Theta Neurofeedback Training on Abstinence Self-Efficacy, Mindfulness, and EEG in Alcohol Use Disorder

Seoul University of Buddhism1 site in 1 country17 target enrollmentStarted: July 1, 2024Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
17
Locations
1
Study OverviewStudy DesignEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This study examined the effects of sequential prefrontal alpha-theta neurofeedback training on abstinence self-efficacy, mindfulness, and brain electroencephalography (EEG) activity in adults with Alcohol Use Disorder (AUD). Participants in the experimental group received 24 sessions of neurofeedback over 8 weeks (3 sessions per week, 30 minutes per session), while a control group received no intervention. EEG and self-report measures were assessed at baseline and post-intervention.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adults diagnosed with Alcohol Use Disorder (AUD) according to Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) criteria
  • •Alcohol Use Disorders Identification Test-Korean (AUDIT-K) score >= 20 (males) or >= 10 (females) indicating high-risk drinking
  • •Voluntary written informed consent

Exclusion Criteria

  • •Sensory impairment (visual or auditory)
  • •Diagnosis of intellectual disability
  • •Current use of antipsychotics, central nervous system stimulants, or sedatives
  • •Active neurological conditions (e.g., epilepsy, recent traumatic brain injury)
  • •Severe psychiatric comorbidities (e.g., active psychosis) contraindicated for EEG-based neurofeedback

Investigators

Sponsor
Seoul University of Buddhism
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yerin Hong

Principal Investigator

Seoul University of Buddhism

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
Using Neurofeedback to Improve Emotional Health in Adolescents with Anxiety and Depression”
CTRI/2025/08/093199Snehaa40
Active, not recruiting
Not Applicable
Neurofeedback in Treatment of Attention Deficit Hyperactivity Disorder
NCT07285681Tanta University40
Not yet recruiting
Not Applicable
Right Dorsolateral Prefrontal Cortex Closed-loop Neurofeedback for Anxiety in High-ischaemic-risk Chronic Coronary SyndromeChronic Coronary SyndromeHigh Ischemic RiskAnxiety Disorder
NCT07543185Shenyang Medical College214
Not yet recruiting
Not Applicable
A clinical trial to study the effect of two treatment strategies, neurofeedback EEG training and virtual reality with body weight supported treadmill training in subjects with incomplete spinal cord injury
CTRI/2024/03/064549Lovely Professional University60
Recruiting
Not Applicable
Effects of rTMS Combined With Dual-Task Gait Training on Walking and Cognition After Stroke
NCT07356687The Hong Kong Polytechnic University184